Emergent biotechnology applications in urology: a mini review

Chang Liu; Alejandro Rivera Ruiz; Yingchun Zhang; Philippe Zimmern; Zhengwei Li

doi:10.3389/fbioe.2025.1539126

Emergent biotechnology applications in urology: a mini review

Chang Liu, Alejandro Rivera Ruiz, Yingchun Zhang, Philippe Zimmern, Zhengwei Li

Research output: Contribution to journal › Short survey › peer-review

Abstract

Technological advances have significantly impacted the field of urology, providing innovative solutions for diagnosis, treatment, and management of various urological disorders and diseases. This article highlights four groundbreaking technologies: whole-cell biosensors, optogenetic interventions for neuromodulation, bioengineered urinary bladder, and 3D bioprinting. Each technology plays a crucial role in enhancing patient care and improving clinical outcomes in urology. Advances in these fields underscore a shift towards precision diagnostics, personalized treatments, and enhanced regenerative strategies, ultimately aiming to enhance patient outcomes and address unmet clinical needs in urological diseases.

Original language	English (US)
Article number	1539126
Journal	Frontiers in Bioengineering and Biotechnology
Volume	13
DOIs	https://doi.org/10.3389/fbioe.2025.1539126
State	Published - 2025

Keywords

3D bioprinting
bioengineered urinary bladder
living cells
optogenetics
urological conditions
whole-cell biosensors

ASJC Scopus subject areas

Biotechnology
Bioengineering
Histology
Biomedical Engineering

Access to Document

10.3389/fbioe.2025.1539126

Cite this

@article{12724f9d25294b6d83c0dc980410c42c,

title = "Emergent biotechnology applications in urology: a mini review",

abstract = "Technological advances have significantly impacted the field of urology, providing innovative solutions for diagnosis, treatment, and management of various urological disorders and diseases. This article highlights four groundbreaking technologies: whole-cell biosensors, optogenetic interventions for neuromodulation, bioengineered urinary bladder, and 3D bioprinting. Each technology plays a crucial role in enhancing patient care and improving clinical outcomes in urology. Advances in these fields underscore a shift towards precision diagnostics, personalized treatments, and enhanced regenerative strategies, ultimately aiming to enhance patient outcomes and address unmet clinical needs in urological diseases.",

keywords = "3D bioprinting, bioengineered urinary bladder, living cells, optogenetics, urological conditions, whole-cell biosensors",

author = "Chang Liu and {Rivera Ruiz}, Alejandro and Yingchun Zhang and Philippe Zimmern and Zhengwei Li",

note = "Publisher Copyright: Copyright {\textcopyright} 2025 Liu, Rivera Ruiz, Zhang, Zimmern and Li.",

year = "2025",

doi = "10.3389/fbioe.2025.1539126",

language = "English (US)",

volume = "13",

journal = "Frontiers in Bioengineering and Biotechnology",

issn = "2296-4185",

publisher = "Frontiers Media SA",

}

TY - JOUR

T1 - Emergent biotechnology applications in urology

T2 - a mini review

AU - Liu, Chang

AU - Rivera Ruiz, Alejandro

AU - Zhang, Yingchun

AU - Zimmern, Philippe

AU - Li, Zhengwei

PY - 2025

Y1 - 2025

N2 - Technological advances have significantly impacted the field of urology, providing innovative solutions for diagnosis, treatment, and management of various urological disorders and diseases. This article highlights four groundbreaking technologies: whole-cell biosensors, optogenetic interventions for neuromodulation, bioengineered urinary bladder, and 3D bioprinting. Each technology plays a crucial role in enhancing patient care and improving clinical outcomes in urology. Advances in these fields underscore a shift towards precision diagnostics, personalized treatments, and enhanced regenerative strategies, ultimately aiming to enhance patient outcomes and address unmet clinical needs in urological diseases.

AB - Technological advances have significantly impacted the field of urology, providing innovative solutions for diagnosis, treatment, and management of various urological disorders and diseases. This article highlights four groundbreaking technologies: whole-cell biosensors, optogenetic interventions for neuromodulation, bioengineered urinary bladder, and 3D bioprinting. Each technology plays a crucial role in enhancing patient care and improving clinical outcomes in urology. Advances in these fields underscore a shift towards precision diagnostics, personalized treatments, and enhanced regenerative strategies, ultimately aiming to enhance patient outcomes and address unmet clinical needs in urological diseases.

KW - 3D bioprinting

KW - bioengineered urinary bladder

KW - living cells

KW - optogenetics

KW - urological conditions

KW - whole-cell biosensors

UR - http://www.scopus.com/inward/record.url?scp=85218195521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85218195521&partnerID=8YFLogxK

U2 - 10.3389/fbioe.2025.1539126

DO - 10.3389/fbioe.2025.1539126

M3 - Short survey

C2 - 39968011

AN - SCOPUS:85218195521

SN - 2296-4185

VL - 13

JO - Frontiers in Bioengineering and Biotechnology

JF - Frontiers in Bioengineering and Biotechnology

M1 - 1539126

ER -

Emergent biotechnology applications in urology: a mini review

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this